GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ACME Laboratories Ltd (DHA:ACMELAB) » Definitions » Gross Margin %

ACME Laboratories (DHA:ACMELAB) Gross Margin % : 42.60% (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is ACME Laboratories Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. ACME Laboratories's Gross Profit for the three months ended in Mar. 2024 was BDT3,410 Mil. ACME Laboratories's Revenue for the three months ended in Mar. 2024 was BDT8,004 Mil. Therefore, ACME Laboratories's Gross Margin % for the quarter that ended in Mar. 2024 was 42.60%.


The historical rank and industry rank for ACME Laboratories's Gross Margin % or its related term are showing as below:

DHA:ACMELAB' s Gross Margin % Range Over the Past 10 Years
Min: 38.28   Med: 39.52   Max: 41.41
Current: 41.41


During the past 8 years, the highest Gross Margin % of ACME Laboratories was 41.41%. The lowest was 38.28%. And the median was 39.52%.

DHA:ACMELAB's Gross Margin % is ranked worse than
61.26% of 986 companies
in the Drug Manufacturers industry
Industry Median: 46.48 vs DHA:ACMELAB: 41.41

ACME Laboratories had a gross margin of 42.60% for the quarter that ended in Mar. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for ACME Laboratories was 0.40% per year.


ACME Laboratories Gross Margin % Historical Data

The historical data trend for ACME Laboratories's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ACME Laboratories Gross Margin % Chart

ACME Laboratories Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Gross Margin %
Get a 7-Day Free Trial 39.40 38.28 38.76 39.67 40.57

ACME Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.72 41.96 40.85 40.72 42.60

Competitive Comparison of ACME Laboratories's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, ACME Laboratories's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ACME Laboratories's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ACME Laboratories's Gross Margin % distribution charts can be found below:

* The bar in red indicates where ACME Laboratories's Gross Margin % falls into.



ACME Laboratories Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

ACME Laboratories's Gross Margin for the fiscal year that ended in Jun. 2023 is calculated as

Gross Margin % (A: Jun. 2023 )=Gross Profit (A: Jun. 2023 ) / Revenue (A: Jun. 2023 )
=10931.7 / 26947.708
=(Revenue - Cost of Goods Sold) / Revenue
=(26947.708 - 16016.001) / 26947.708
=40.57 %

ACME Laboratories's Gross Margin for the quarter that ended in Mar. 2024 is calculated as


Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=3409.5 / 8004.48
=(Revenue - Cost of Goods Sold) / Revenue
=(8004.48 - 4594.953) / 8004.48
=42.60 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


ACME Laboratories  (DHA:ACMELAB) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

ACME Laboratories had a gross margin of 42.60% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


ACME Laboratories Gross Margin % Related Terms

Thank you for viewing the detailed overview of ACME Laboratories's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


ACME Laboratories (DHA:ACMELAB) Business Description

Traded in Other Exchanges
N/A
Address
1/4, Kallayanpur, Mirpur Road, Court de la ACME, Dhaka, BGD, 1207
ACME Laboratories Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products in Bangladesh. The company offers pharmaceutical, ayurvedic, herbal, nutraceutical products, and veterinary products. It produces various forms of dosage including tablet, capsule, dry syrup, cream, ointment, powder and injection among others.

ACME Laboratories (DHA:ACMELAB) Headlines

No Headlines